Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in china

HIGHLIGHTS

• who: Dandan Guan from the a multicenter, retrospective study in Chinapatients who received NAC were enrolled between , and , from Shanghai Jiaotong University Breast Cancer have published the research work: Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China, in the Journal: (JOURNAL) of December/31,/2021
• what: This study aims to screen for some predictors and investigate the prognostic significance of pCR after NAC in HR+ HER2- BC in China . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.